Embryonic vs. Adult Stem Cells in Research Essay -- Argumentative Pers

Embryonic vs. Adult Stem Cells in Research Why is the mainstream media significantly downplaying exciting scientific discoveries with adult bag cells? This essay hopes to adequately answer that question. Heres the scoop As originally inform late last year in the medical journal Blood, Dr. Catherine M. Verfaillie and opposite researchers at the Stem Cell Institute, University of Minnesota, have discovered a trend to coax an adult cell found in the bone summation to exhibit many of the attributes that supposedly make embryonal stem cells unexpendable to the development future miracle medical therapies(Catherine). While there is still a lot research to be done, multi-potent adult progenitor cells (MAPCs) come on to be versatile, that is, equal of transforming into different types of tissues. (In a culture dish, the cells can be coaxed into becoming muscle, cartilage, bone, liver, or different types of neurons in the brain.) They are also malleable, meaning they can do so rel atively easily. They also exhibit the immortality valued in embryonic cells, that is to say, they seem capable of being transformed into cell lines that can be maintained indefinitely. At the same time, these adult cells do not appear to present the acute danger associated with embryonic stem cells the tendency to spring up uncontrollably causing tumors or even cancers. This should be a coarse story considering the intense controversy over embryonic-stem-cell research (ESCR) and the coming hear in the United States Senate to outlaw human cloning (S.790). Indeed, the New York propagation and Washington Post consider embryonic-stem-cell research so important - including the formulate and use of human-clone embryos in such experiments - that both hav... ...hat the biotech researchers say more true up then whatever cloning/ESCR opponents may argue - regardless of the echt evidence. Finally, clout in public-policy disputes usually boils down to money. Quite often, reporters dont decide stories stories find reporters. That is how PR firms make the big bucks being paid quite handsomely to alert journalists to stories their clients want covered. In this fight, Big Biotechs very deep pockets just about guarantee coverage that is skewed in favor of destroying human embryos in experiments and permitting the creation of human-research clones. Sources Consulted Catherine Verfaillie http//www1.umn.edu/stemcell/sci/page/fac-mbr/verfaillie/verfaillie.shtml New Scientist http//www.newscientist.com/ New York Times http//www.nytimes.com/auth/login?URI=http//www.nytimes.com/2002/01/25/ perception/25STEM.html